Female Doctor Explaining Nanoparticles
First Asian Patient
Female Doctor
Image is not available
previous arrow
next arrow

NBTXR3 First in Class Radioenhancer

Physical Mode of Action that could work across all solid tumors to enhance radiotherapy efficacy.

Only one administration

Fits into existing standard of care:

  • No change in equipment
  • No change in current patient flow
  • No change in protocol
  • One product addressing areas of high unmet medical needs.

    See more

    Recent Press Releases

    NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023
    Voting Rights and Shares Capital of the Company
    NANOBIOTIX to Postpone Full Year 2022 Financial Results and Conference Call



    “Being part of Nanobiotix is a privilege. The privilege of exploring beyond the edge of science and challenging established and existing limits for the good of humankind. The privilege of being part of an extraordinary adventure to enable people to live a better life. The privilege of expanding life.”

    Anne-Juliette Hermant
    Chief People Officer

    Download our latest
    Corporate Presentation